ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,709.54
      0.01%
      US Tech 100
      19,316.02
      0.34%
      Dow Jones
      42,196.52
      0.09%
      Brent Oil
      74.615
      0.26%
      Bitcoin
      60,669.86
      -0.27%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Oric Pharmaceuticals Inc (ORIC)

      7. Oric Pharmaceuticals Inc (ORIC) News

      Oric Pharmaceuticals Inc

      Oric Pharmaceuticals Inc (ORIC)

      NASDAQ
      9.79
      -0.25
      (-2.49%)
      At close: October 02 4:00PM
      Delayed by 15 minutes
      9.31
      -0.48
      ( -4.90% )
      After Hours: 6:16PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      ORIC News

      Official News Only

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      August 12 2024
      ORIC (-2.49%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      August 12 2024
      ORIC (-2.49%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 14 2024
      ORIC (-2.49%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      May 06 2024
      ORIC (-2.49%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      May 06 2024
      ORIC (-2.49%)

      ORIC Discussion

      View Posts
      Monksdream Monksdream 4 weeks ago
      ORIC under $10
      👍️0
      Monksdream Monksdream 3 months ago
      ORIC under $10
      👍️0
      Monksdream Monksdream 3 months ago
      ORIC under $10
      👍️0
      Monksdream Monksdream 5 months ago
      ORIC 10Q due 5/6
      👍️0
      Monksdream Monksdream 5 months ago
      ORIC under $10
      👍️0
      Monksdream Monksdream 7 months ago
      ORIC 10Q due 3/16
      👍️0
      Monksdream Monksdream 7 months ago
      ORIC new 52 week high
      👍️0
      Monksdream Monksdream 7 months ago
      ORIC new 52 week high
      👍️0
      Monksdream Monksdream 7 months ago
      ORIC new 52 week high
      👍️0
      Monksdream Monksdream 8 months ago
      ORIC new 52 weewk high
      👍️0
      Monksdream Monksdream 8 months ago
      ORIC new 52 week high
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      $ORIC LOOKS LIKE $6 COMING
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC: Tapped $5.40....... still got steam

      It ain't over yet





      GO $ORIC
      👍️0
      DH112 DH112 2 years ago
      Today is green fields
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      Pfizer will pay $4.65 per share for 5,376,344 of Oric's common shares, for a total of $25 million. The companies plan to move the treatment into a Phase 2 clinical trial in combination with elranatamab, Pfizer's investigational treatment of multiple myeloma

      https://finance.yahoo.com/news/oric-pharmaceuticals-announces-clinical-development-224800151.html
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC: 5.25 now........................... lets get to $10

      I know you can do it babyyyyyyyyyyyyyyyyy


      GO $ORIC
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC : Now at 4.90

      YESsssssssssssssss............ this is very impressive news with deal with Pfizer.

      Me likes it


      GO $ORIC
      👍️0
      crudeoil24 crudeoil24 2 years ago
      Shares of Oric Pharmaceuticals Inc. jumped nearly 60% to $4.79 in premarket trading Thursday after the company agreed to sell $25 million in shares to Pfizer Inc.

      The clinical-stage oncology company said Wednesday evening that Pfizer has agreed to buy nearly 5.4 million shares of Oric's common stock for $4.65 apiece.

      The investment is part of a clinical development collaboration between the two companies on a Phase 2 study examining Oric's ORIC-533 treatment for multiple myeloma, the companies said.

      The companies said the collaboration would potentially advance the treatment into a combination study with Pfizer's elranatamab, an investigational treatment for multiple myeloma.


      Write to Dean Seal at dean.seal@wsj.com


      (END) Dow Jones Newswires

      December 22, 2022 07:25 ET (12:25 GMT)
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC: BOOOoommmmmmm........... Pfiizer invests $25Milly in ORIC

      Letssssssss goooooooooooooooooo.


      Added 5k shares here at 4.30

      Great NEWS


      https://www.tipranks.com/news/oric-pharmaceuticals-nasdaqoric-stock-spikes-on-pfizer-deal

      GO $ORIC
      👍️0

      Your Recent History

      NASDAQ
      ORIC
      Oric Pharmaceuticals
      Delayed Upgrade Clock